【発明の名称】ムスカリンレセプターアンタゴニスト活性を有するカルバメート誘導体

Japanese Patent JP2003516390

A

This invention relates to hindered carbamate derivatives that are muscarinic receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of preparing these compounds.

JP2762509	INDUSTRIAL APPLICABILITY [title of invention] Pyranobenzoxadiazole derivative
JPS6413087	4-((ALPHA,ALPHA-DIARYL)-HYDROXYMETHYL)-1-PIPERIDINYLALKYL-CYCLIC CARBAMATE DERIVATIVE
WO/2005/084672	SELECTED CGRP-ANTAGONISTS, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS

Maman, mate
Oar, david

JP2001543513A

May 13, 2003

December 07, 2000

Click for automatic bibliography generation  

Celavans Incorporated

A61K31/445; A61K31/4468; A61K31/451; A61K31/4523; A61K31/4525; A61K31/4535; A61K31/454; A61K31/4545; A61K31/47; A61K31/473; A61K31/496; A61K31/506; A61K31/5377; A61K31/55; A61K31/551; A61P1/00; A61P1/02; A61P1/04; A61P11/00; A61P11/06; A61P13/02; A61P13/10; A61P25/08; C07D487/08; A61P25/28; A61P27/02; A61P43/00; C07D211/48; C07D211/52; C07D211/58; C07D211/60; C07D211/62; C07D211/64; C07D211/66; C07D401/06; C07D401/12; C07D401/14; C07D405/12; C07D409/12; C07D413/06; C07D413/12; C07D417/14; C07D453/02; C07D471/04; C07D471/08; C07D471/10; C07D471/14; C07D487/10; C07D491/08; C07D491/10; C07D495/08; (IPC1-7): C07D211/48; A61K31/445; A61K31/4545; A61K31/47; A61K31/496; A61K31/506; A61K31/5377; A61K31/55; A61K31/551; A61P1/04; A61P11/00; A61P11/06; A61P13/02; A61P25/08; A61P27/02; A61P43/00; C07D401/12; C07D401/14; C07D405/12; C07D409/12; C07D413/06; C07D471/10; C07D471/14

Shusaku Yamamoto (2 outside)

Previous Patent: アミコマイシン、その製造方法および医薬品としてのその使用

Next Patent: ムスカリン性レセプターアンタゴニスト活性を有するウレア化合物